Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus NVEQUITIES | 500,000 | 645,581 | +145,581 | $11.79M | $17.75M | 5.48% | +$5.96M |
| Mersana Therapeutics IncEQUITIES | 5,000,000 | 6,420,136 | +1,420,136 | $6.35M | $14.89M | 4.59% | +$8.54M |
| Morphic Holding IncEQUITIES | 590,829 | 500,042 | -90,787 | $13.54M | $14.44M | 4.45% | +$905.3K |
| Nuvalent IncEQUITIES | 0 | 193,000 | +193,000 | $0 | $14.20M | 4.38% | +$14.20M |
| Poseida Therapeutics IncEQUITIES | 3,567,985 | 3,705,779 | +137,794 | $8.49M | $12.45M | 3.84% | +$3.96M |
| MacroGenics, Inc.EQUITIES(MGNX) | 1,264,158 | 1,258,641 | -5,517 | $5.89M | $12.11M | 3.73% | +$6.22M |
| Rocket Pharmaceuticals, Inc.EQUITIES(RCKT) | 0 | 382,672 | +382,672 | $0 | $11.47M | 3.54% | +$11.47M |
| Medtronic plcEQUITIES(MDT) | 0 | 135,000 | +135,000 | $0 | $11.12M | 3.43% | +$11.12M |
| SanofiEQUITIES(SNY) | 0 | 220,000 | +220,000 | $0 | $10.94M | 3.37% | +$10.94M |
| ORIC Pharmaceuticals, Inc.EQUITIES(ORIC) | 1,123,345 | 1,170,000 | +46,655 | $6.80M | $10.76M | 3.32% | +$3.97M |
| Celldex Therapeutics, Inc.EQUITIES(CLDX) | 0 | 247,215 | +247,215 | $0 | $9.80M | 3.02% | +$9.80M |
| Olema Pharmaceuticals, Inc.EQUITIES(OLMA) | 407,801 | 573,830 | +166,029 | $5.04M | $8.05M | 2.48% | +$3.01M |
| Rhythm Pharmaceuticals, Inc.EQUITIES(RYTM) | 260,537 | 174,248 | -86,289 | $5.97M | $8.01M | 2.47% | +$2.04M |
| UroGen Pharma Ltd.EQUITIES(URGN) | 508,883 | 525,404 | +16,521 | $7.13M | $7.88M | 2.43% | +$751.6K |
| Xenon Pharmaceuticals Inc.EQUITIES(XENE) | 53,996 | 163,168 | +109,172 | $1.84M | $7.52M | 2.32% | +$5.67M |
| Veracyte, Inc.EQUITIES(VCYT) | 239,571 | 247,723 | +8,152 | $5.35M | $6.81M | 2.10% | +$1.47M |
| Praxis Precision Medicines, Inc.EQUITIES(PRAX) | 0 | 283,841 | +283,841 | $0 | $6.32M | 1.95% | +$6.32M |
| Akero Therapeutics IncEQUITIES | 31,336 | 249,254 | +217,918 | $1.58M | $5.82M | 1.79% | +$4.24M |
| Pliant Therapeutics, Inc.EQUITIES(PLRX) | 250,409 | 318,524 | +68,115 | $4.34M | $5.77M | 1.78% | +$1.43M |
| Intra-Cellular Therapies IncEQUITIES | 208,730 | 80,000 | -128,730 | $10.87M | $5.73M | 1.77% | -$5.14M |
| Cogent Biosciences, Inc.EQUITIES(COGT) | 651,372 | 966,748 | +315,376 | $6.35M | $5.68M | 1.75% | -$666.4K |
| Alpine Immune Sciences IncEQUITIES | 0 | 297,789 | +297,789 | $0 | $5.68M | 1.75% | +$5.68M |
| Gossamer Bio, Inc.EQUITIES(GOSS) | 6,130,268 | 6,130,268 | 0 | $5.11M | $5.59M | 1.73% | +$488.6K |
| Intuitive Surgical, Inc.EQUITIES(ISRG) | 0 | 15,808 | +15,808 | $0 | $5.33M | 1.64% | +$5.33M |
| TELA Bio, Inc.EQUITIES(TELA) | 490,471 | 795,080 | +304,609 | $3.92M | $5.26M | 1.62% | +$1.34M |
| Biogen Inc.EQUITIES(BIIB) | 28,069 | 20,000 | -8,069 | $7.21M | $5.18M | 1.60% | -$2.04M |
| CymaBay Therapeutics IncEQUITIES | 590,000 | 218,975 | -371,025 | $8.80M | $5.17M | 1.60% | -$3.62M |
| Caribou Biosciences, Inc.EQUITIES(CRBU) | 892,786 | 900,818 | +8,032 | $4.27M | $5.16M | 1.59% | +$894.2K |
| Scholar Rock Holding CorporationEQUITIES(SRRK) | 9,711 | 270,000 | +260,289 | $68.9K | $5.08M | 1.57% | +$5.01M |
| Penumbra, Inc.EQUITIES(PEN) | 0 | 20,000 | +20,000 | $0 | $5.03M | 1.55% | +$5.03M |
| Insmed IncorporatedEQUITIES(INSM) | 150,387 | 155,504 | +5,117 | $3.80M | $4.82M | 1.49% | +$1.02M |
| Sarepta Therapeutics, Inc.EQUITIES(SRPT) | 9,197 | 46,884 | +37,687 | $1.11M | $4.52M | 1.39% | +$3.41M |
| DexCom, Inc.EQUITIES(DXCM) | 0 | 31,000 | +31,000 | $0 | $3.85M | 1.19% | +$3.85M |
| Solid Biosciences IncEQUITIES | 0 | 594,855 | +594,855 | $0 | $3.65M | 1.13% | +$3.65M |
| United Therapeutics CorporationEQUITIES(UTHR) | 31,424 | 16,360 | -15,064 | $7.10M | $3.60M | 1.11% | -$3.50M |
| Terns Pharmaceuticals IncEQUITIES | 500,000 | 516,999 | +16,999 | $2.52M | $3.36M | 1.03% | +$840.3K |
| Cerus CorporationEQUITIES(CERS) | 1,203,890 | 1,499,851 | +295,961 | $1.95M | $3.24M | 1.00% | +$1.29M |
| Kodiak Sciences Inc.EQUITIES(KOD) | 1,114,461 | 1,000,000 | -114,461 | $2.01M | $3.04M | 0.94% | +$1.03M |
| Biohaven Ltd.EQUITIES(BHVN) | 10,000 | 70,695 | +60,695 | $260.1K | $3.03M | 0.93% | +$2.77M |
| MoonLake ImmunotherapeuticsEQUITIES(MLTX) | 0 | 50,000 | +50,000 | $0 | $3.02M | 0.93% | +$3.02M |
| Soleno Therapeutics IncEQUITIES | 370,000 | 73,665 | -296,335 | $10.92M | $2.97M | 0.91% | -$7.95M |
| Evogene LtdEQUITIES | 3,100,000 | 3,100,000 | 0 | $1.82M | $2.60M | 0.80% | +$785.9K |
| Mirum Pharmaceuticals, Inc.EQUITIES(MIRM) | 110,114 | 80,811 | -29,303 | $3.48M | $2.39M | 0.74% | -$1.09M |
| Zura Bio LimitedEQUITIES(ZURA) | 404,040 | 462,997 | +58,957 | $2.67M | $2.16M | 0.67% | -$504.5K |
| Annexon, Inc.EQUITIES(ANNX) | 399,716 | 417,429 | +17,713 | $943.3K | $1.90M | 0.58% | +$951.8K |
| Compugen Ltd.EQUITIES(CGEN) | 350,188 | 940,000 | +589,812 | $325.7K | $1.86M | 0.57% | +$1.54M |
| argenx SEEQUITIES(ARGX) | 0 | 4,826 | +4,826 | $0 | $1.84M | 0.57% | +$1.84M |
| 89bio IncEQUITIES | 60,247 | 158,719 | +98,472 | $930.2K | $1.77M | 0.55% | +$842.7K |
| PMV Pharmaceuticals, Inc.EQUITIES(PMVP) | 0 | 550,000 | +550,000 | $0 | $1.71M | 0.53% | +$1.71M |
| Altimmune, Inc.EQUITIES(ALT) | 0 | 150,000 | +150,000 | $0 | $1.69M | 0.52% | +$1.69M |
| Intellia Therapeutics, Inc.EQUITIES(NTLA) | 53,018 | 54,822 | +1,804 | $1.68M | $1.67M | 0.52% | -$4.9K |
| BioCryst Pharmaceuticals, Inc.EQUITIES(BCRX) | 791,671 | 248,728 | -542,943 | $5.61M | $1.49M | 0.46% | -$4.12M |
| KalVista Pharmaceuticals IncEQUITIES | 228,934 | 111,734 | -117,200 | $2.20M | $1.37M | 0.42% | -$835.9K |
| Molecular Templates IncEQUITIES | 354,608 | 354,608 | 0 | $2.24M | $1.32M | 0.41% | -$918.4K |
| Trevi Therapeutics, Inc.EQUITIES(TRVI) | 927,415 | 863,883 | -63,532 | $2.02M | $1.16M | 0.36% | -$864.2K |
| Schrödinger, Inc.EQUITIES(SDGR) | 30,311 | 31,117 | +806 | $856.9K | $1.11M | 0.34% | +$257.1K |
| Viridian Therapeutics, Inc.EQUITIES(VRDN) | 47,438 | 50,438 | +3,000 | $727.7K | $1.10M | 0.34% | +$370.8K |
| Immunovant, Inc.EQUITIES(IMVT) | 0 | 20,000 | +20,000 | $0 | $842.6K | 0.26% | +$842.6K |
| Apellis Pharmaceuticals IncEQUITIES COM | 0 | 10,000 | +10,000 | $0 | $598.6K | 0.18% | +$598.6K |
| Karyopharm Therapeutics Inc.EQUITIES(KPTI) | 561,955 | 561,955 | 0 | $753.0K | $486.1K | 0.15% | -$266.9K |
| Aligos Therapeutics IncEQUITIES | 631,887 | 668,512 | +36,625 | $472.0K | $443.9K | 0.14% | -$28.1K |
| Relmada Therapeutics, Inc.EQUITIES(RLMD) | 100,000 | 100,000 | 0 | $300.0K | $414.0K | 0.13% | +$114.0K |
| Rezolute, Inc.EQUITIES(RZLT) | 433,240 | 157,085 | -276,155 | $571.9K | $155.9K | 0.05% | -$416.0K |
| Rocket Pharmaceuticals, Inc.WARRANTS(RCKT) | 104,828 | 104,828 | 0 | $17.8K | $51.4K | 0.02% | +$33.5K |
| Aerovate Therapeutics IncEQUITIES | 100,000 | 0 | -100,000 | $1.36M | $0 | — | -$1.36M |
| Alkermes PlcEQUITIES(ALKS) | 41,455 | 0 | -41,455 | $1.16M | $0 | — | -$1.16M |
| BioMarin Pharmaceutical IncEQUITIES(BMRN) | 10,000 | 0 | -10,000 | $884.8K | $0 | — | -$884.8K |
| Clene IncEQUITIES(CLNN) | 500,000 | 0 | -500,000 | $247.9K | $0 | — | -$247.9K |
| Crinetics Pharmaceuticals IncEQUITIES(CRNX) | 220,000 | 0 | -220,000 | $6.54M | $0 | — | -$6.54M |
| Eliem Therapeutics IncEQUITIES(CLYM) | 121,110 | 0 | -121,110 | $318.5K | $0 | — | -$318.5K |
| Eloxx Pharmaceuticals IncEQUITIES | 54,075 | 0 | -54,075 | $260.1K | $0 | — | -$260.1K |
| Gilead Sciences IncEQUITIES(GILD) | 62,789 | 0 | -62,789 | $4.71M | $0 | — | -$4.71M |
| Humana IncEQUITIES(HUM) | 10,000 | 0 | -10,000 | $4.87M | $0 | — | -$4.87M |
| ImmunoGen IncEQUITIES | 1,307,435 | 0 | -1,307,435 | $20.75M | $0 | — | -$20.75M |
| Krystal Biotech IncEQUITIES(KRYS) | 71,531 | 0 | -71,531 | $8.30M | $0 | — | -$8.30M |
| Mirati Therapeutics IncEQUITIES | 200,000 | 0 | -200,000 | $8.71M | $0 | — | -$8.71M |
| Novo Nordisk A/SEQUITIES(NVO) | 60,000 | 0 | -60,000 | $5.46M | $0 | — | -$5.46M |
| Point Biopharma Global IncEQUITIES | 93,700 | 0 | -93,700 | $625.0K | $0 | — | -$625.0K |
| Praxis Precision Medicines IncEQUITIES | 4,117,920 | 0 | -4,117,920 | $7.04M | $0 | — | -$7.04M |
| Prothena Corporation PLCEQUITIES SHS | 26,629 | 0 | -26,629 | $1.28M | $0 | — | -$1.28M |
| Roivant Sciences LtdEQUITIES(ROIV) | 100,000 | 0 | -100,000 | $1.17M | $0 | — | -$1.17M |
| Sagimet Biosciences IncEQUITIES(SGMT) | 100,000 | 0 | -100,000 | $880.0K | $0 | — | -$880.0K |
| Syndax Pharmaceuticals IncEQUITIES(SNDX) | 20,000 | 0 | -20,000 | $290.4K | $0 | — | -$290.4K |
| Vertex Pharmaceuticals IncEQUITIES(VRTX) | 13,765 | 0 | -13,765 | $4.79M | $0 | — | -$4.79M |
| Voyager Therapeutics IncEQUITIES(VYGR) | 103,966 | 0 | -103,966 | $805.7K | $0 | — | -$805.7K |